Case Report: Management of Adverse Drug Reaction in Patient with Urogenital Tuberculosis İlaç Alerjisi Gelişen Ürogenital Tüberküloz Vakası: Olgu Sunumu


Açar C., BABALIK A.

Journal of Uludag University Medical Faculty, cilt.49, sa.2, ss.273-276, 2023 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.32708/uutfd.1264193
  • Dergi Adı: Journal of Uludag University Medical Faculty
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.273-276
  • Anahtar Kelimeler: Adverse drug reaction, Extrapulmonary tuberculosis, Urogenital tuberculosis
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Inhalation of tuberculosis bacillus triggers immune response and as a result it causes elimination of the causetive agent or it may end up with the manifestation of primary infection. In most of the cases, %95 of primary tuberculosis infection results in containment and enters the latent period whereas around %5 of the cases result progressive primary tuberculosis, at this stage mycobacterium may spread to adjacent and extrapulmonary tissues via hematogenous and lymphatic spread. If reactivation occurs in foci out of lungs, then extrapulmonary tuberculosis arises. Urogenital tuberculosis (UG-TB) is the third most common site of extrapulmonary tuberculosis following pleural tuberculosis and peripheral lympadenopathy. Kidneys are usually infected via hemotogenous spread of the bacillus from the lungs. Chest radiograph reveals no specific findings in almost half of the UG-TB cases. Untreated disease may result renal parenchyma damage and obstructive nephropathy and as a result end-stage renal disease occurs. In this case it is mentioned about hypersensitivity drug reaction that occured in patient with the diagnosis of urogenital tuberculosis.